190 related articles for article (PubMed ID: 34279414)
1. Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells.
Dalla Pozza M; Orvain C; Brustolin L; Pettenuzzo N; Nardon C; Gaiddon C; Fregona D
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279414
[TBL] [Abstract][Full Text] [Related]
2. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
[TBL] [Abstract][Full Text] [Related]
3. Noble metal-dithiocarbamates precious allies in the fight against cancer.
Nagy EM; Ronconi L; Nardon C; Fregona D
Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
[TBL] [Abstract][Full Text] [Related]
4. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
Ronconi L; Fregona D
Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
[TBL] [Abstract][Full Text] [Related]
5. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes.
Brustolin L; Nardon C; Pettenuzzo N; Zuin Fantoni N; Quarta S; Chiara F; Gambalunga A; Trevisan A; Marchiò L; Pontisso P; Fregona D
Dalton Trans; 2018 Nov; 47(43):15477-15486. PubMed ID: 30334060
[TBL] [Abstract][Full Text] [Related]
7. Cu
Pettenuzzo N; Brustolin L; Coltri E; Gambalunga A; Chiara F; Trevisan A; Biondi B; Nardon C; Fregona D
ChemMedChem; 2019 Jun; 14(12):1162-1172. PubMed ID: 31091012
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble Ru(II)-anethole compounds with promising cytotoxicity toward the human gastric cancer cell line AGS.
Carrillo E; Ramírez-Rivera S; Bernal G; Aquea G; Tessini C; Thomet FA
Life Sci; 2019 Jan; 217():193-201. PubMed ID: 30528721
[TBL] [Abstract][Full Text] [Related]
9. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
10. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
11. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
[TBL] [Abstract][Full Text] [Related]
12. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
[TBL] [Abstract][Full Text] [Related]
14. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
[TBL] [Abstract][Full Text] [Related]
15. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
Nardon C; Brustolin L; Fregona D
Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601
[TBL] [Abstract][Full Text] [Related]
16. Gold (III) Derivatives in Colon Cancer Treatment.
Gurba A; Taciak P; Sacharczuk M; Młynarczuk-Biały I; Bujalska-Zadrożny M; Fichna J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054907
[TBL] [Abstract][Full Text] [Related]
17. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
18. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
20. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
Pal M; Nandi U; Mukherjee D
Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
